Patent · US Active

Methods for treating pulmonary hypertension

US10441590B2 · kind B2 · utility

1Cited by
2References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 7, 2017
Grant dateOct 15, 2019
Priority date
Expiry dateJul 7, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a method of using arylpiperazine derivatives for treating pulmonary hypertension. The method comprises a step of administering to a patient in need thereof an effective amount of a compound of Formula 1, which is an arylpiperazine derivative.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.